What 29 Drugs Face FDA Approval in 2012?

Here's an updated list of biotech and pharmaceutical companies with pending FDA drug approval decisions for the rest of 2012. The calendar on the following pages captures the most important U.S. regulatory events -- FDA drug approvals and advisory panels -- expected between May and December 2012. As every savvy biotech investor and trader knows, the volatility in biotech and drug stocks ramps significantly as U.S. regulators weigh whether to approve or reject new drugs.